Lobbying & Influence

Work on Capitol Hill? Enjoy free access.

An Ad Blitz That Really Worked?

Biotech Industry Gets a Big Win on Biologics

By Kate Ackley
Roll Call Staff
July 15, 2009, Midnight

A highly targeted lobbying and advertising campaign by the biotechnology and pharmaceutical industries paid off this week when a Senate panel writing health care reform legislation swung their way on the issue of biologic drugs.

Obama’s Modification to Contraception Rule Mollifies Some, Not All 6 minutes ago
Bachus May Not Be Alone in Ethics Probe 41 minutes ago
Nine Things We've Learned at CPAC (So Far) 11:48 a.m.
Obama to Offer Birth Control Rule Compromise 11:16 a.m.
Cain Explains
Space Nazis Vs. Earth: What Would Gingrich Do?
Harry Reid to GOP: ‘Calm Down’ About Birth Control Rule

Slideshow |

February 9, 2012

Rep. Michele Bachmann, who recently suspended her campaign for the presidency, speaks at the 2012 Conservative Political Action Conference in Washington, D.C., on Feb. 9.

See More Multimedia

Email Newsletter Sign-Up

Breaking News Alerts
Morning and Afternoon Headlines
Heard on the Hill Updates

Follow Roll Call:

30 Hill Aides to Know

The clear expectation is Congress will get very little done this election year. But what does get accomplished, at least in the high-profile areas, will largely be the handiwork of an elite group of staffers — who combine policy expertise, political acumen and the trust of their lawmaker bosses to drive much of the legislative agenda.

Lobbying & Influence

An Ad Blitz That Really Worked?

Biotech Industry Gets a Big Win on Biologics

Slideshow |

Email Newsletter Sign-Up

Follow Roll Call:

30 Hill Aides to Know

SIGN IN

SUBSCRIBE

Lobbying & Influence

An Ad Blitz That Really Worked?

Biotech Industry Gets a Big Win on Biologics

More News

Slideshow |

Email Newsletter Sign-Up

Follow Roll Call:

30 Hill Aides to Know

SIGN IN

SUBSCRIBE